Apex Infusion partners with SkyNight Capital as it seeks market expansion

SAN FRANCISCO – Apex Infusion, an omnichannel infusion services provider, has entered into a definitive agreement to partner with SkyKnight Capital, a private equity firm, to drive the company’s next chapter of growth.

Apex's clinician-led management team will retain a significant ownership stake and continue to lead the business. FFL Partners will also remain a minority investor in the company.

“Apex has reached an exciting milestone,” said Rick Smith, executive chairman and co-founder of Apex. “We have built a differentiated platform, established strong relationships across the health care ecosystem, and proven that our model can scale rapidly. With SkyKnight and FFL, we are well positioned to accelerate our expansion and extend Apex’s model of care to more patients nationwide.”

Founded in 2006 and headquartered in Signal Hill, Calif., Apex serves patients through an expansive network of home infusion nurses and approximately 40 ambulatory infusion suite locations.

Apex says SkyKnight will support the company as it evaluates opportunities for new market expansion, strategic partnerships with leading health systems and payers, and technology-enabled initiatives designed to enhance patient access.

"What our team has built at Apex is something special – a best-in-class infusion platform designed to optimize the patient experience at every step,” said Moussie Haile, PharmD, CEO and co-founder of Apex. “By delivering therapy in a comfortable clinical setting or the familiarity of home, we give patients better outcomes, greater dignity and a real improvement in their quality of life. As we enter this next chapter, our priority remains unchanged: to preserve the clinical culture that defines Apex while bringing our high standard of care to more patients and communities."

The partnership is subject to customary closing conditions, including the receipt of required regulatory approvals.